Deal Library / Pharma BD Deal Intelligence

Hikma Pharmaceuticals PLC — Pharma Deals

The Pharma Closeout tracks 4 deals, $2.6B in disclosed deal value, 1 with a post-close Outcome Score for Hikma Pharmaceuticals PLC.

Median Critic Score: 63  ·  Median Outcome Score: 29

All 4 deals

• Hikma Pharmaceuticals PLC / Boehringer Ingelheim (Roxane Laboratories Inc. and Boehringer Ingelheim Roxane Inc.) — 2015 · $2.6B · Did not work — the deal failed to deliver.
• Hikma Pharmaceuticals PLC / Emergent BioSolutions — 2025
• Hikma Pharmaceuticals PLC / Shanghai Junshi Biosciences Co., Ltd. — 2022
• Hikma Pharmaceuticals PLC / Glenmark Specialty S.A. — 2020

← Deal Library  ·  Interactive search  ·  How we score deals